Skip to Content

Hanmi Science Co Ltd 008930

Morningstar Rating
KRW 33,500.00 +200.00 (0.60%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

008930 is trading within a range we consider fairly valued.
Price
KRW 33,084.53
Fair Value
KRW 73,915.52
Uncertainty
Very High
1-Star Price
KRW 792,667.53
5-Star Price
KRW 98,527.64
Economic Moat
Ynkly
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 008930 is a good fit for your portfolio.

Trading Information

Previous Close Price
KRW 33,300.00
Day Range
KRW 33,250.0033,600.00
52-Week Range
KRW 29,850.0056,200.00
Bid/Ask
KRW 33,300.00 / KRW 33,600.00
Market Cap
KRW 2.27 Tril
Volume/Avg
57,224 / 402,817

Key Statistics

Price/Earnings (Normalized)
22.11
Price/Sales
1.83
Dividend Yield (Trailing)
0.60%
Dividend Yield (Forward)
0.60%
Total Yield
0.94%

Company Profile

Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Growth
Total Number of Employees
421

Comparables

Valuation

Metric
008930
271980
000100
Price/Earnings (Normalized)
22.1136.0652.92
Price/Book Value
2.891.512.56
Price/Sales
1.830.332.86
Price/Cash Flow
37.2615.2234.88
Price/Earnings
008930
271980
000100

Financial Strength

Metric
008930
271980
000100
Quick Ratio
0.360.631.54
Current Ratio
0.691.002.15
Interest Coverage
13.781.1520.59
Quick Ratio
008930
271980
000100

Profitability

Metric
008930
271980
000100
Return on Assets (Normalized)
10.01%1.45%5.71%
Return on Equity (Normalized)
15.05%4.28%7.43%
Return on Invested Capital (Normalized)
12.80%4.70%6.50%
Return on Assets
008930
271980
000100
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpNhvhbdjtWjjtyc$71.0 Bil
COR
Cencora IncJfsqhsbnkVwmcys$48.0 Bil
CAH
Cardinal Health IncFxyskvfnKmvcrst$25.1 Bil
SHTDF
Sinopharm Group Co LtdPvmgggf$8.6 Bil
SHTDY
Sinopharm Group Co Ltd ADRDhjkgw$8.6 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HMkkgz$8.2 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HPvmpz$8.2 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoMcslvyv$7.6 Bil
MEPDF
Medipal Holdings CorpZtqw$3.3 Bil
MAHLY
Medipal Holdings Corp ADRMxw$3.3 Bil

Sponsor Center